DROXIA 6335 DROXIA 6335 (Droxia 200 mg)

Generic Name: hydroxyurea

Pill imprint DROXIA 6335 DROXIA 6335 has been identified as Droxia 200 mg.

Droxia is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for DROXIA 6335 DROXIA 6335 (Droxia 200 mg)

Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia
Generic Name:
hydroxyurea
Imprint:
DROXIA 6335
DROXIA 6335
Strength:
200 mg
Color:
Green
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-6335
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web3)